Indraprastha Apollo Hospitals launches Radixact – X9 for cancer patients

Indraprastha Apollo Hospital, Delhi has launched the most advanced version of Tomotherapy Radixact X9 for treatment of cancer patients. Tomotherapy comes as a boon for cancer treatment since it has a higher degree of precision, speed and accuracy. Patients find it more comfortable to be treated under this technology owing to the rotational helical mechanism, also the set-up time is lesser as compared to other therapies.

Cancer is the leading cause of death in India and worldwide. According to reports by National Health Profile, cancer cases have risen. Most of the cancers can be treated if diagnosed at an early stage. Tomotherapy is effective in treating cancer, irrespective of the stage, especially multiple metastasis. The best outcomes are for treatment of bilateral breast cancer, paediatric oncology and all other forms of cancer.

Addressing the launch ceremony, Suneeta Reddy, Managing Director, Apollo Hospitals Group, said, “The launch of the most advanced version of the Tomotherapy technology is truly a remarkable development in the field of radiation oncology. This will be a revolutionary step in the treatment of cancer. With this system, we can deliver both fractionated radiotherapy as well as SBRT and radiosurgery. The launch of the most advance version of tomotherapy reinforces our commitment to delivering excellent radiation therapy treatment for cancer patients in Delhi/NCR and neighbouring states. The new generation radiation machine and our highly experienced team enables us to move ahead towards precise and personalised care, therefore improving the quality of life of cancer patients and ensure better clinical outcomes.”

Highlighting the key features of Tomotherapy, P ShivaKumar, Managing Director, Indraprastha Apollo Hospitals, said, “We are taking precision and excellence to the next level with the revolutionary Radixact-X9: Tomotherapy, system powered by state-of-the-art 3D CT imaging. It uses a linear accelerator to deliver high-dose radiation to the tumour with sub-millimetre precision. With the most recent introduction of Radixact X9, radiation oncology has reached a new horizon in the race of effective curative treatment for cancer. Large field size can be targeted at once. 1.35 cms of length can be targeted without repositioning the machine.”